Thus, indiscriminate iron supplementation to treat anaemia triggered by inflammation can override this host‐defense mechanism and lead to increases in the concentration of non‐transferrin bound iron, which has been linked to increased morbidity and mortality (Baye, 2019; Hurrell, 2010). This evidence concerns the gene TF and anemia (phenotype).